How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bariatric Surgery Market
- By Surgery Type: Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Intragastric Balloon
- By Patient Age Group: Adult (18-64 years), Adolescent (13-17 years), Elderly (65 years and above)
- By End-User: Hospitals, Bariatric Surgery Clinics, Ambulatory Surgical Centers
- By Surgical Approach: Laparoscopic Surgery, Open Surgery, Robotic-Assisted Surgery
- By Indication: Morbid Obesity, Severe Obesity with Comorbidities, Obesity with Type 2 Diabetes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Roux-en-Y Gastric Bypass leads By Surgery Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Bariatric Surgery Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Surgery Type 5
Patient Age Group 3
End-User 3
Surgical Approach 3
Indication 3
Companies profiled
Medtronic plc
Johnson & Johnson (Ethicon)
Apollo Endosurgery Inc.
Intuitive Surgical Inc.
Stryker Corporation
B. Braun Melsungen AG
ConMed Corporation
LivaNova PLC
Zimmer Biomet Holdings Inc.
Smith & Nephew plc
Cook Medical Inc.
W.L. Gore & Associates Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Johnson & Johnson (Ethicon)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Apollo Endosurgery Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ConMed Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →LivaNova PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Zimmer Biomet Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smith & Nephew plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cook Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →W.L. Gore & Associates Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Becton
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Dickinson and Company (BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Terumo Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Olympus Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,380M by 2033 · 7.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Roux-en-Y Gastric Bypass30.6
- Sleeve Gastrectomy23.6
- Adjustable Gastric Banding9.6
- Biliopancreatic Diversion with Duodenal Switch19.9
- Intragastric Balloon16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,218M → $1,950M · 6.1%
Europe$849.2M → $1,585M · 8.1%
Asia Pacific$775.4M → $1,432M · 8.0%
Latin America$480.0M → $754.2M · 5.8%
Middle East and Africa$369.2M → $694.4M · 8.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.032026
7.042027
7.062028
7.062029
7.072030
7.092031
7.092032
7.112033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic plc12.8
- Johnson & Johnson (Ethicon)16.4
- Apollo Endosurgery Inc.13.5
- Intuitive Surgical Inc.12.7
- Stryker Corporation6.3
- B. Braun Melsungen AG10.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgery Type14.7%
Patient Age Group29.2%
End-User24.1%
Surgical Approach21.9%
Indication10.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.4
- Europe24.7
- Asia Pacific22.3
- Latin America11.8
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 96 | 85 | 86 | 73 | 97 | 89 | 88 |
| Johnson & Johnson (Ethicon) | 82 | 79 | 75 | 93 | 86 | 84 | 83 |
| Apollo Endosurgery Inc. | 87 | 86 | 75 | 72 | 81 | 82 | 81 |
| Intuitive Surgical Inc. | 79 | 59 | 72 | 69 | 57 | 59 | 66 |
| Stryker Corporation | 75 | 69 | 65 | 56 | 56 | 71 | 65 |
| B. Braun Melsungen AG | 59 | 47 | 69 | 57 | 59 | 47 | 56 |
| ConMed Corporation | 43 | 65 | 54 | 56 | 55 | 46 | 53 |
| LivaNova PLC | 41 | 40 | 49 | 50 | 39 | 44 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic plc
- Johnson & Johnson (Ethicon)
- Apollo Endosurgery Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic plc | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Johnson & Johnson (Ethicon) | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Apollo Endosurgery Inc. | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Intuitive Surgical Inc. | ◐ | − | ✓ | ◐ | ◐ | − |
| Stryker Corporation | ✓ | ◐ | ◐ | − | ◐ | ◐ |
| B. Braun Melsungen AG | ◐ | − | ◐ | − | − | ◐ |
| ConMed Corporation | − | ◐ | ◐ | − | − | − |
| LivaNova PLC | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic plc88
2Johnson & Johnson (Ethicon)83
3Apollo Endosurgery Inc.81
4Intuitive Surgical Inc.66
5Stryker Corporation65
6B. Braun Melsungen AG56
7ConMed Corporation53
8LivaNova PLC44
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Medtronic plcJohnson & Johnson (Ethicon)Apollo Endosurgery Inc.
Contender2
Focused players with pockets of strength.
Intuitive Surgical Inc.Stryker Corporation
Niche3
Specialists in a single segment or region.
B. Braun Melsungen AGConMed CorporationLivaNova PLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgery Type in North America, then scale across Bariatric Surgery Market — a $569M beachhead inside a $8.33B market.
Beachhead (SOM)$569Mobtainable near-term
Serviceable (SAM)$3.01Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Roux-en-Y Gastric Bypass
Best fit — highest urgency & budget in Surgery Type.
Economic buyer81 fit
Sleeve Gastrectomy
Strong fit — clear ROI and a fast path to value.
End user67 fit
Adjustable Gastric Banding
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgery Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Patient Age Group & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Surgery Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bariatric Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified23%
Evaluation15%
Closed-won8%
$15.6KCAC
$77KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Bariatric Surgery Market is a resilient opportunity — $4.70B by 2033, compounding at 4.7%.
TAM · 2025$3.25Btoday
TAM · 2033$4.70Bforecast
CAGR4.7%2027–2033
Cumulative$35.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.70BTotal addressable market
SAM$1.60BServiceable available market
SOM$277MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.7% CAGR
Demand compounds through 2033, outpacing GDP across Surgery Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgery Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.70BLarge & growingTAM by 2033 at 4.7% CAGR
$1.60BServiceable nowreachable with today’s model
$277MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.67BBear3.1% CAGR
$4.70BBase4.7% CAGR
$6.02BBull6.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Patient Age Group optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Bariatric Surgery Market — a $1.34B market by 2033. Plan: grow share from 8.2% to 16.2%.
Market size · 2033$1.34Btotal addressable
Market CAGR8.5%2027–2033
Target share16.2%from 8.2% today
Revenue ambition$216Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 16.2% | At risk |
| Revenue | $120M | $216M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.3% | 38.8% | On track |
| Customer retention | 87.4% | 96.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgery Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Patient Age Group capability
A defensible second engine — invest in Patient Age Group to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgery Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Patient Age Group
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $27M capacity & capability investment
- Greenlight bolt-on M&A in Patient Age Group
- Authorise North America expansion plan
- Fund R&D program for Surgery Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Bariatric Surgery Market conversation — a $8.57B market you can size, segment and defend in minutes.
Market size · 2033$8.57Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers1,098+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgery Type
Goal Grow share in Surgery Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Medtronic plcJohnson & Johnson (Ethicon)Apollo Endosurgery Inc.Intuitive Surgical Inc.Stryker CorporationB. Braun Melsungen AGConMed CorporationLivaNova PLC+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bariatric Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bariatric Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bariatric Trolleys Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportBaricitinib(CAS 1187594-09-7) Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportBarista Robot Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBarite Mining Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportBarium & Its Derivatives Market
Market size, share, segmentation and regional forecast.
$377M market · 2025 base year
View reportBarium acetate CAS 543-80-6 Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBarium and Chromium and Their Derivatives Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportBarium Borate (Bbo) Crystal Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBarium Borate Oxide (Bbo) Crystal Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportBARIUM BROMATE CAS 13967-90-3 Market
Market size, share, segmentation and regional forecast.
$375M market · 2025 base year
View reportBarium chromate CAS 10294-40-3 Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBarium Derivatives Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.